Ubiquitin-like 5 pseudogene 1 (UBL5P1)

Ubiquitin-like 5 pseudogene 1 (UBL5P1) is classified as a pseudogene, meaning it is a segment of DNA resembling a gene but generally incapable of encoding a functional protein. Pseudogenes may arise through processes such as gene duplication or retrotransposition and can accumulate mutations that abrogate protein-coding potential. However, growing evidence indicates that some pseudogenes have biological functions, primarily acting at the RNA level. They can serve as sources for noncoding RNAs, act as decoys for microRNAs, or contribute regulatory small interfering RNAs that modulate gene expression, sometimes influencing the expression of related genes. While there is evidence for such regulatory roles broadly among pseudogenes, there are no published data supporting any direct, unique, or clinically actionable role for UBL5P1 specifically as a therapeutic target, biomarker, or drug-interacting molecule[2][4][5][7].\n\nKey contextual note:\n- UBL5P1 is sometimes annotated in gene catalogs and product lists, but these references consistently identify it as a non-functional pseudogene, not a canonical therapeutic target[3][5][7].\n- Pseudogenes, including UBL5P1, are not typically considered drug targets in pharmacology or clinical research. Their main scientific interest is as potential regulatory elements or as markers in genomic studies[2][6][4].\n- Some pseudogenes are transcribed and may produce regulatory RNAs, but most do not lead to functional peptides or proteins[4][2][6].\n\nIn summary, "Ubiquitin-like 5 pseudogene 1 (UBL5P1)" is a pseudogene not regarded as a druggable target, receptor, or pharmacologically relevant entity.

Other names

UBL5P1Ubiquitin like 5 pseudogene 1